Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neuralstem Inc (NASDAQ:CUR)

1.73
Delayed Data
As of Jul 31
 +0.03 / +1.76%
Today’s Change
1.46
Today|||52-Week Range
4.11
-36.40%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$156.3M

Company Description

Neuralstem, Inc. is a biopharmaceutical company, which is focused on the development and commercialization of treatments based on human neuronal stem cells and small molecule compounds. It develops biotherapeutic products to treat and cure neurodegenerative conditions and in regenerative repair of acute disease. The company was founded by I. Richard Garr, Karl Johe and Merrill Solomon in 1996 and is headquartered in Germantown, MD.

Contact Information

Neuralstem, Inc.
20271 Goldenrod Lane
Germantown Maryland 20876
P:(301) 366-4960
Investor Relations:
(301) 366-1481

Employees

Shareholders

Individual stakeholders7.69%
Other institutional12.44%
Mutual fund holders10.12%

Top Executives

Karl Y. JoheChairman & Chief Scientific Officer
I. Richard GarrPresident, CEO, Director & Legal Counsel
Jonathan B. Lloyd JonesChief Financial Officer
Thomas HazelSenior Vice President-Research
Danielle SpanglerHead-Investor Relations